EPISODE · Oct 27, 2021 · 18 MIN
Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.
New research shows that a widely available antidepressant could be even more effective than a new pill from Merck at treating Covid-19. And it's much less expensive.Speaking of that pill, Merck will allow a nonprofit group to manufacture it for low and middle income countries. But it won't allow for a generic option.The FDA is expected to give final approval to Pfizer's vaccine for 5 to 11 year old kids later this week. How much resistance will we see from parents?Yet another thing made worse by the pandemic: Childhood obesity. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Embed this episode
Ready to play
Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.